Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

Journal of Infection

Volumn 65, Issue 6, 2012, Pages 588-591

  Hoenigl, Martin ^a   Koidl, Christoph ^a   Duettmann, Wiebke ^a   Seeber, Katharina ^a   Wagner, Jasmin ^a   Buzina, Walter ^a   Wölfler, Albert ^a   Raggam, Reinhard B ^a   Thornton, Christopher R ^b   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; ORGAN TRANSPLANTATION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

ANTIGENS, FUNGAL; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS;

EID: 84869091822     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.10.003     Document Type: Letter

References (10)

1. Park S.Y., Lee S.O., Choi S.H., Sung H., Kim M.N., Choi C.M., et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010 Dec, 61(6):492-498.
2. Hoenigl M., Salzer H.J., Raggam R.B., Valentin T., Rohn A., Woelfler A., et al. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol 2012 Apr, 50(3):266-269.
3. Thornton C., Johnson G., Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp 2012 Mar 22, (61). pii:3721. 10.3791/3721.
4. Thornton C.R. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008 Jul, 15(7):1095-1105.
5. Wiederhold N.P., Thornton C.R., Najvar L.K., Kirkpatrick W.R., Bocanegra R., Patterson T.F. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccine Immunol 2009 Dec, 16(12):1844-1846.
6. Hoenigl M., Strenger V., Buzina W., Valentin T., Koidl C., Wolfler A., et al. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother 2012 Aug, 67(8):2029-2033.
7. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 Jun 15, 46(12):1813-1821.
8. Becker M.J., Lugtenburg E.J., Cornelissen J.J., Van Der Schee C., Hoogsteden H.C., De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003 May, 121(3):448-457.
9. Azoulay E., Dupont H., Tabah A., Lortholary O., Stahl J.P., Francais A., et al. Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med 2012 Mar, 40(3):813-822.
10. van der Linden J.W., Snelders E., Kampinga G.A., Rijnders B.J., Mattsson E., Debets-Ossenkopp Y.J., et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis 2011 Oct, 17(10):1846-1854.